Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
50-60 range by Oct/Nov
Do you plan on selling in the 16s?
Also - I exclusively follow you on IHub - wanted to thank you for all the gains I’ve realized the past couple years.
Cheers
Ask up to .045 in the AM
This little guy just may get some big wings
Today’s the day
Looks like the price is about to suffer until then. Hopefully it comes soon
Would’ve thought we’d see buyers lining up right away here at this consolidated price
What’s goin on with the bid/ask ?
thinking the news has yet to see enough eyes, but will explode once it does.
NETANYA, Israel, June 29, 2018 (GLOBE NEWSWIRE) -- RADA Electronic Industries Ltd. (RADA) announced today that its Multi-Mission Hemispheric Radar (MHR), has been selected as part of the Leonardo DRS mission equipment package (MEP) solution, for the US Army’s Initial Maneuver-Short Range Air Defense (IM-SHORAD) capability. DRS is in negotiations with the US Army for this prototype contract which is expected to be awarded in August 2018.
Could have a little gem here
I do remember the Cannabix Management team... do you...?
1/22/2018:
Team Cannabix = Validated Rockstars
2 Mars!
/////AMG
I think Refinery29 NAILED it here:
Dec. 5th, 2015:
“Hound Labs’ device will be tested by law enforcement officers in the San Francisco Bay Area. If tests are successful, the laboratory hopes to begin sales at the end of 2016”
https://www.refinery29.com/2015/12/98935/marijuana-breathilyzer-clinical-trials
Let’s take a look at Hound Labs timeline:
Dec. 2nd, 2015
“Clinical trials will begin next quarter in partnership with the University of California, San Francisco and San Francisco General Hospital.”
Sep 13th, 2016
“Hound Labs, Inc. will continue to conduct rigorous testing”
May 23rd, 2017
“The first clinical trials began earlier this month at San Francisco General Hospital (SFGH).”
“Hound Labs plans to begin manufacturing the Hound marijuana breathalyzer in the fourth quarter of 2017.”
March 19th, 2018
“Hound Labs continues to conduct research with Triple Ring Technologies using the Hound marijuana and alcohol breathalyzer. Clinical trials with UCSF are ongoing.”
Source:
https://houndlabs.com/press-release/
“They have exactly what they say they have”
LOL
How’s the bid price ......
They’ve handed out some sh*t sandwich PRs, yes. However, you’d think there would be much more frequent “news” releases of fluff pumping sandwiches if they didn’t think their breathalyzer had a legit chance at coming to fruition.
So while we are all starving for substantial updates to shift the chart’s direction and provide peace of mind while we wait, one can optimistically view the lack of frequent News as a positive.
BLOZF Long?
They never mention anything about any devices. So unfortunately, this kind of sounds like bad news for us. They wouldn’t be spending tens of millions of dollars to train officers on how to do drug impaired sobriety tests if they thought a viable detection device was coming. One that undoubtably will be costly to purchase and to train officers on using it properly.
Struggling to get past this level. Volume low. Hmm
MJ is decriminalized in NY if it’s not a massive amount. And since there’s no reliable way (yet!) of determining whether or not someone’s high while they’re behind the wheel at that time, a citation seems appropriate over making an arrest
Sounds like a breakdown of accurate recency measurement will be presented. Fingers crossed it gets tied to our Breathalyzer
$RCM
Great time to buy this massive BULL. Next run coming soon, will bring this over $9 per then 10+ shortly after. $13-15+ per share by the end of the year. $25-30+ per share by the end of next year. Do some DD, it’s there...much more to come from this fun ride. Safe to long this beast!
Up almost 10% today without News.
Hmm??
$RCM (Link Back)
Monster that still isn’t closed to done. Longggg this BULL
Monster day! More to come??
It’s all about $RCM in this area. Much more to come with that stock
Got it, thanks! What a ride. Now let’s see $THM get past this hurdle finally
How high can this beast climb!
$RCM (Link Back)
Tens of dollars coming. Long this one hard. 30+ in the next couple years
$RCM (Link Back)
I hear you loud and clear AMG. You posted on a public forum. Addressed to Shell, public nonetheless!
I appreciate all of your posts and your perspective/insight. Couldn’t care less if the feeling is mutual but I chose to aim my self-assuring optimistic post towards you. I suppose it would have been more appropriate if I responded to your post with that little timeline you included at the bottom.
I digress in my efforts to self-assure.
BlOzF lOnG
Rome wasn’t built in a day...
Bringing brand new technology through conception and into the market takes time, especially when law enforcements a significant piece of your target market. We are entering our 5th year here, which to investors may seem like a lifetime, but in all reality, it is pretty standard. Take the beloved comparison TASR. They filed for a patent and it was 5+ years before they developed the device.
Do they need more money? Maybe. More money more power. More avenues to take when the time comes.
We all hungry here
Agreed. Been saying the same thing
3 dollars+ awaits
Cannabix Technologies Files FAIMS Cannabis Detection Patent - Enters into License Agreement with University of Florida and Provides Technology Update
For immediate release. Vancouver, British Columbia, April 16, 2018: Cannabix Technologies Inc.(CSE: BLO, OTC PINK: BLOZF) (the “Company”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report it has filed a Patent Cooperation Treaty (“PCT”) application titled, “Device and Method for Detection of Cannabis and Other Controlled Substances Using FAIMS” (PCT/CA2017/000042). This PCT covers intellectual property related to earlier versions of the Cannabix Marijuana Breathalyzer. Under its relationship with the University of Florida (“the University”), the Company has entered into a second license agreement with the University for PCT application CA2017/000042. The agreement provides Cannabix exclusive worldwide rights in the area of breath analysis of controlled substances. Cannabix is developing an innovative FAIMS (field asymmetric waveform ion mobility spectrometry) based instrument for the detection of ?9-tetrahydrocannabinol in human breath.
In recent months the Company has been characterizing its Beta 3.0 Cannabix Marijuana Breathalyzer prototype performance measures both independently and coupled to a mass spectrometer (MS), in preparation for expanded field testing. This work has led to the design and development of several improvements to the device which are now being incorporated. The characterizing work has focused on better separation of several analytes in human breath that are similar in molecular mass and geometry to THC. Testing has included further temperature characterization and flow control. A unique gating system has been developed that allows switching between the standalone FAIMS detector and a conventional MS enabling rapid alternation between both mechanisms during a single breath, proving enhanced analysis capability.
THC and related metabolite characterization
Marijuana contains several cannabinoids in addition to ?9-tetrahydrocannabinol (“THC”). Many of these have shorter half-lives and are metabolized in the body relatively quickly. THC can be detectable in blood for weeks, whereas metabolites such as 11-hydroxy-delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol are only detectable for a few hours after consumption of cannabis. The Cannabix FAIMS device has demonstrated the detection of THC and related metabolites in MS-coupled testing. The detection of THC and its metabolites in human breath provides for real-time pharmacokinetic analysis. Such analysis provides a method for the identification of “recency of use” and also provides analysis of frequent users of marijuana who tend to retain THC in their body for longer periods of time, relative to infrequent marijuana users who tend to clear THC from their body more quickly. This data and analysis will be important for an eventual court approved device, furthermore, 11-nor-9- carboxy-tetrahydrocannabinol is the primary metabolite from the liver, which is prevalent from the consumption of edibles. Cannabix scientists are working quickly to complete this characterization stage.
The Company also reports that it has renewed its ongoing research agreement for 2018 with the Dr. Yost lab at the University of Florida.
I have made a pretty penny off of some of your plays lately. And for that, I thank you very much good sir.
Id like to repay the favor. I posted this one a while back but if you haven’t checked it out yet, you should look into $RCM.
Long play but a beautiful bull. Heading to double digits easily. Will be $30+ in coming years.
Cheers
Maybe they’ll hit the News button while climbing
Is .80 your buy trigger?